Fong Bryant 4
4 · ADMA BIOLOGICS, INC. · Filed Mar 9, 2022
Insider Transaction Report
Form 4
Fong Bryant
Director
Transactions
- Award
Employee Stock Option (right to buy)
2022-03-07+53,172→ 53,172 totalExercise: $1.67Exp: 2032-03-07→ Common Stock (53,172 underlying) - Award
Common Stock
2022-03-07+26,586→ 34,086 total
Holdings
- 1,433,304(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.
- [F2]Includes (i) 26,586 RSUs granted on March 7, 2022 and reported on this Form 4, subject to vesting as set forth in footnote (1); and (ii) 7,500 shares of common stock owned by the reporting person.
- [F3]Represents shares held by Biomark Capital Fund ("Biomark Capital"). Mr. Fong is a Managing Director and General Partner at Biomark Capital and may be deemed the beneficial owner of such shares.
- [F4]The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.